1979 Company founded in the village of Penn, Buckinghamshire, England

1986 Obtained manufacturing licence from MHRA

1986 Company moved to its current site at Tredegar, South Wales

1986 Obtained 'Specials' manufacturing licence from MHRA

1990 Established Clinical Trial Supplies department

1995 Established Analytical Development laboratory and Formulation Development department

1997 First successful NDA application support for FDA licensed product

2001 Construction of 16 room GMP manufacturing facility

2003 Construction of temperature controlled warehouse

2003 Achieved IiP and Queens Award for Enterprise: International Trade Category

2004 Obtained manufacturing licence for IMPs (Investigational Medicinal Products)

2005 Awarded ISO 14001 and Green Dragon Level 5 environmental standards

2005 Establishment of Penn sales office in Tokyo, Japan

2006 IiP re-accreditation and Environmental Gold Standard Award

2007 Peter George CEO leads £67m management buy-out with Lloyds Development Capital (LDC)

2007 Refurbishment and expansion of analytical and microbiology laboratories

2007 Establishment of US subsidiary and US based business development team

2008 Refurbishment and expansion of secondary packing rooms

2008 Opening of new high containment manufacturing facility (Jan 2008)

2008 Opening of additional 75,000 sq.ft temperature controlled warehouse (Apr 2008)